5AM Partners IV, LLC
10% owner at Pear Therapeutics, Inc.; 10% owner at scPharmaceuticals Inc.; 10% owner at APRE
- Sold, on record
- $17.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Nov 2, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- Pear Therapeutics, Inc.10% owner
- scPharmaceuticals Inc.10% owner
- APREAprea Therapeutics, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- APRE500,000 shares
- scPharmaceuticals Inc.226,622 shares
- Pear Therapeutics, Inc.54,209 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale APREUnusualMay 19, 2020 2020
Sold 255,000 shares at $35.15 ($9M)
5AM Partners IV, LLC, 10% owner
Sold 73.8% of holdings ($12.1M position)90,572 shares leftFirst sale on recordFiling
- 2 Form 4 sale APREUnusualJun 11, 2020 +23 days
Sold 245,000 shares at $28.75 ($7M)
5AM Partners IV, LLC, 10% owner
Sold 75.2% of holdings ($9.4M position)80,772 shares leftFiling
- 3 Form 4 sale scPharmaceuticals Inc.UnusualSep 7, 2022 +818 days
Sold 226,622 shares at $4.84 ($1.1M)
5AM Partners IV, LLC, 10% owner
Sold 31.1% of holdings ($3.5M position)503,112 shares leftFirst sale on recordFiling
- 4 Form 4 sale Pear Therapeutics, Inc.Plan not statedNov 2, 2022 +56 days
Sold 54,209 shares at $2.77 ($150k)
5AM Partners IV, LLC, 10% owner
Sold 9.1% of holdings ($1.6M position)539,066 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2022 | Nov 2, 2022 | Pear Therapeutics, Inc. | 10% owner | Form 4 sale | 54,209 | $150k | 9.1% | Plan not stated | SEC |
| Sep 7, 2022 | Sep 8, 2022 | scPharmaceuticals Inc. | 10% owner | Form 4 sale | 226,622 | $1.1M | 31.1% | Unusual | SEC |
| Jun 11, 2020 | Jun 15, 2020 | APRE | 10% owner | Form 4 sale | 245,000 | $7M | 75.2% | Unusual | SEC |
| May 19, 2020 | May 21, 2020 | APRE | 10% owner | Form 4 sale | 255,000 | $9M | 73.8% | Unusual | SEC |